Atellica CH Triglycerides Diagnostic Kit Recalled for Reagent Carryover
Siemens Healthcare Diagnostics is recalling 11,824 units of Atellica CH Triglycerides test kits due to reagent carryover from other test parameters that can affect magnesium measurement accuracy. The FDA classified this as a Class II recall.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II medical device recall involving diagnostic test accuracy. The hazard presents a confirmed risk of incorrect test results that could affect diagnostic reliability, but no illnesses or injuries have been reported. This meets the criterion of risk-of-harm products where injury has not yet been reported.
Plain-English summary
Siemens Healthcare Diagnostics, Inc. is recalling 11,824 units of Atellica CH Triglycerides (concentrated) diagnostic test kits. These in vitro diagnostic tests are designed to measure triglyceride levels in human serum and plasma samples using the Atellica CH Analyzer.
The recall was initiated because reagent carryover from multiple test parameters—LDL Cholesterol Direct (DLDL), Total Protein II (TP), Triglycerides (Trig), and Triglycerides_2 (Trig_2)—can affect the accuracy of magnesium measurement results. This carryover may lead to incorrect test outcomes.
The affected test kits were distributed nationwide and internationally to more than 50 countries, including Canada, Mexico, the United Kingdom, France, Germany, Japan, China, and Australia. The FDA classified this as a Class II recall (recall number Z-1270-2023).
The recalled product
- Product
- Atellica CH Triglycerides (concentrated)-In vitro diagnostic use in the quantitative measurement of triglycerides in human serum and plasma (lithium heparin, potassium EDTA) using the Atellica CH Analyzer SMN: 11097591
- Manufacturer
- Siemens Healthcare Diagnostics, Inc.
- Affected units
- 11,824
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- UDI: 00630414596495 All Lots
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 4 recalled by Siemens Healthcare Diagnostics, Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same manufacturer · Siemens Healthcare Diagnostics, Inc.
See all →- SevereSiemens Recalls Emit 2000 Quinidine Assay Due to Precision Issues
FDA (Devices) · 2026-08-26
- SevereSiemens Quinidine Assay Recalled for Precision Errors
FDA (Devices) · 2026-08-26
- HighSiemens Atellica CH Urine Albumin In Vitro Diagnostic Recall
FDA (Devices) · 2026-08-12
- ModerateSiemens Tricyclic Antidepressant Calibrator/Controls Recall Lot U2
FDA (Devices) · 2026-08-12
- LowSyva Emit Disopyramide Enzyme Immunoassay Calibrator Recalled for Sodium Azide Concentration
FDA (Devices) · 2026-08-12
Same hazard · reagent carryover
See all →- HighSiemens Atellica CH diagnostic reagent carryover may cause false laboratory test results
FDA (Devices) · 2023-09-06
- ModerateSiemens Atellica CH Total Protein II Recalled for Reagent Carryover
FDA (Devices) · 2023-09-06
- HighLaboratory diagnostic test may produce inaccurate results from reagent carryover
FDA (Devices) · 2023-09-06
- HighSiemens Atellica CH Analyzer: Reagent Carryover Affecting Magnesium Test Results
FDA (Devices) · 2023-09-06
- HighSiemens Atellica CH LDL Cholesterol analyzer reagent carryover issue
FDA (Devices) · 2023-09-06